There is growing evidence that lncRNA MEG3 expression is dysregulated during various diseases, including cancers, Huntington's disease, Parkinson's disease, cardiovascular diseases, bone diseases, and ischemic stroke. The gene discussed is MEG3; the disease is ischemic stroke.